Enliven Therapeutics (ELVN) Current Leases (2022 - 2026)
Enliven Therapeutics (ELVN) posted Current Leases of $597,000 for Q2 2026, up 58.8% from $376,000 a year earlier and up 97.7% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Current Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Current Leases came in at $399,000.
- Annual Current Leases shows a three-year compound annual growth rate of 7.3% (FY2022 to FY2025).
- In prior years, Enliven Therapeutics' Current Leases was $335,000 in FY2023 (+3.7%) and $323,000 in FY2022.
- The Q2 2026 figure stands as the highest quarterly Current Leases in data going back to Q4 2022.
- On a year-over-year basis, Current Leases increased in four of the last six quarters, with growth averaging 81.6%.
- The strongest year-over-year quarter for Current Leases in the past five years was Q3 2025, with growth of 355.3%; the weakest was Q3 2024, with a decline of 74.4%.
- According to Business Quant data, Current Leases for the three prior quarters was $302,000 (Q1 2026), $399,000 (Q4 2025) and $387,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Enliven Therapeutics | 3.37 Bn | 3.37 Bn | - | 597,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 597,000.00 |
| Mar 31, 2026 | 302,000.00 |
| Dec 31, 2025 | 399,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | 376,000.00 |
| Mar 31, 2025 | 365,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 252,000.00 |
| Dec 31, 2023 | 335,000.00 |
| Sep 30, 2023 | 332,000.00 |
| Jun 30, 2023 | 329,000.00 |
| Dec 31, 2022 | 323,000.00 |
API Access
Enliven Therapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();